Sandercock, PeterLindley, RichardWardlaw, JoannaDennis, MartinInnes, KarenCohen, GeoffWhiteley, WillPerry, DavidSoosay, VeraBuchanan, DavidVenables, GrahamCzlonkowska, AnnaKobayashi, AdamBerge, EivindSlot, Karsten BruinsMurray, VeronicaPeeters, AndreHankey, Graeme JMatz, KarlBrainin, MichaelRicci, StefanoCantisani, Teresa AGubitz, GordonPhillips, Stephen JAntonio, ArauzCorreia, ManuelLyrer, PhillippeKane, IngridLundstrom, ErikIST-3 Collaborative GroupMyint, Phyo Kyaw2016-01-052016-01-052011-11-30Sandercock, P, Lindley, R, Wardlaw, J, Dennis, M, Innes, K, Cohen, G, Whiteley, W, Perry, D, Soosay, V, Buchanan, D, Venables, G, Czlonkowska, A, Kobayashi, A, Berge, E, Slot, K B, Murray, V, Peeters, A, Hankey, G J, Matz, K, Brainin, M, Ricci, S, Cantisani, T A, Gubitz, G, Phillips, S J, Antonio, A, Correia, M, Lyrer, P, Kane, I, Lundstrom, E, IST-3 Collaborative Group & Myint, P K 2011, 'Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited', Trials, vol. 12, 252. https://doi.org/10.1186/1745-6215-12-2521745-6215ORCID: /0000-0001-8512-4368/work/95223116ORCID: /0000-0003-3852-6158/work/163198826http://hdl.handle.net/2164/532810478526engacute diseasebrain ischemiadouble-blind methodfibrinolytic agentshumansprospective studiessample sizestrokethrombolytic therapytissue plasminogen activatorR MedicineRJournal article10.1186/1745-6215-12-25212